The European single cell multiomics market, valued at $527.9 million in 2021, is poised for significant growth, with projections indicating an annual growth rate of 18.0% over the decade from 2021 to ...

Parse Biosciences has announced an expansion of its Evercode™ WT Mega Kit functionality. The company says researchers can now analyze up to 384 samples and one million cells in a single run, unlocking ...

Parse Biosciences, a leader in accessible and scalable single cell sequencing solutions, today announced a significant expansion of its Evercode™ WT Mega Kit functionality. Researchers can now ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

In this edition of “Rising High,” The Fly conducted an exclusive interview with Erez Aminov, Chairman & Chief Executive Officer of MIRA ...

Swedish immuno-oncology firm Alligator Bioscience (STO: ATORX) saw its shares jump more than 13% to 0.26 kronor this morning, as it announced the positive outcome of regulatory interactions with the ...

The Midlands Integrative Biosciences Training Partnership is a BBSRC-funded doctoral training partnership between the universities of Warwick, Birmingham, Leicester, Aston, Harper Adams and Coventry.

In a move that blurs the line between science fiction and reality, Colossal Biosciences, the pioneering de-extinction company backed by countless celebs, has secured $200 million in Series C funding.

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation ...

Image courtesy of Colossal Biosciences.(Colossal Biosciences) Colossal Biosciences announced Wednesday it had reached a $10 billion valuation, putting it in rare territory among Texas startups.